Prospective data collection on patients with rare bleeding disorders (PRO-RBDD)

Recruiting

• Conditions: Bloedstollingsafwijkingen; bleeding disorder

• Registration Number: NL-OMON44839
• Lead Sponsor: Angelo Bianchi Bonomi Hemophilia and Trombosis Center - University of Milan and Luigi Villa Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Severe, moderate or mild congenital deficiency of one of the following coagulation factors: fibrinogen (factor I); prothrombin (factor II); factor V; factor V+VIII; factor VII; factor X; factor XI; factor XIII.

Exclusion Criteria

Vitamin K deficiency or other anti-coagulants.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Laboratory phenotype and genotype, type / site / number of spontaneous<br /><br>bleedings or triggered episodes, treatment use, efficacy, and safety.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>